133 related articles for article (PubMed ID: 15052276)
1. Regarding the cardiovascular effects of an herbal ephedra-caffeine weight loss product.
Rawson ES; Persky AM
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1353-4. PubMed ID: 15052276
[No Abstract] [Full Text] [Related]
2. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
Kalman DS
Int J Obes Relat Metab Disord; 2004 Oct; 28(10):1355-6. PubMed ID: 15365583
[No Abstract] [Full Text] [Related]
3. Banning ephedra: good call, poor vision.
Gordon JS
Altern Ther Health Med; 2004; 10(6):18-9. PubMed ID: 15624346
[No Abstract] [Full Text] [Related]
4. An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults.
Kalman D; Incledon T; Gaunaurd I; Schwartz H; Krieger D
Int J Obes Relat Metab Disord; 2002 Oct; 26(10):1363-6. PubMed ID: 12355332
[TBL] [Abstract][Full Text] [Related]
5. FDA to ban sales of dietary supplements containing ephedra.
Ling AM
J Law Med Ethics; 2004; 32(1):184-6. PubMed ID: 15152444
[No Abstract] [Full Text] [Related]
6. It's still "buyer beware" for a popular weight loss herb.
Heart Advis; 2004 Mar; 7(3):2. PubMed ID: 15195607
[No Abstract] [Full Text] [Related]
7. Psychosis related to ephedra-containing herbal supplement use.
Walton R; Manos GH
South Med J; 2003 Jul; 96(7):718-20. PubMed ID: 12940331
[TBL] [Abstract][Full Text] [Related]
8. [Ephedrine and ephedra in weight loss products and other preparations].
van der Hooft CS; Stricker BH
Ned Tijdschr Geneeskd; 2002 Jul; 146(28):1335-6. PubMed ID: 12148223
[TBL] [Abstract][Full Text] [Related]
9. Ephedra banned.
Cockey CD
AWHONN Lifelines; 2004; 8(1):19-25. PubMed ID: 15031882
[No Abstract] [Full Text] [Related]
10. Periconceptional use of weight loss products including ephedra and the association with birth defects.
Bitsko RH; Reefhuis J; Louik C; Werler M; Feldkamp ML; Waller DK; Frias J; Honein MA;
Birth Defects Res A Clin Mol Teratol; 2008 Aug; 82(8):553-62. PubMed ID: 18553492
[TBL] [Abstract][Full Text] [Related]
11. FDA v. ephedra: is it time to lift the ban?
Pyle KR
Food Drug Law J; 2006; 61(4):701-51. PubMed ID: 17180770
[No Abstract] [Full Text] [Related]
12. Citrus aurantium as a thermogenic, weight-reduction replacement for ephedra: an overview.
Preuss HG; DiFerdinando D; Bagchi M; Bagchi D
J Med; 2002; 33(1-4):247-64. PubMed ID: 12939122
[TBL] [Abstract][Full Text] [Related]
13. Over-the-counter products for weight management.
Beall J
Ala Nurse; 2007; 34(3):11-2. PubMed ID: 17970292
[No Abstract] [Full Text] [Related]
14. Potential risks associated with the use of herbal anti-obesity products.
Chan TY
Drug Saf; 2009; 32(6):453-6. PubMed ID: 19459713
[TBL] [Abstract][Full Text] [Related]
15. Ephedra in perspective--a current review.
Abourashed EA; El-Alfy AT; Khan IA; Walker L
Phytother Res; 2003 Aug; 17(7):703-12. PubMed ID: 12916063
[TBL] [Abstract][Full Text] [Related]
16. [Health risks raised by ephedra in food supplements].
van Riel AJ; de Vries I; Meulenbelt J
Ned Tijdschr Geneeskd; 2003 Oct; 147(41):2017-9. PubMed ID: 14587144
[TBL] [Abstract][Full Text] [Related]
17. The relative safety of ephedra compared with other herbal products.
Kingston RL; Borron SW
Ann Intern Med; 2003 Sep; 139(5 Pt 1):385; author reply 386-7. PubMed ID: 12965952
[No Abstract] [Full Text] [Related]
18. The relative safety of ephedra compared with other herbal products.
Dickinson A
Ann Intern Med; 2003 Sep; 139(5 Pt 1):385; author reply 386-7. PubMed ID: 12965951
[No Abstract] [Full Text] [Related]
19. The relative safety of ephedra compared with other herbal products.
Whitaker JM
Ann Intern Med; 2003 Sep; 139(5 Pt 1):385; author reply 386-7. PubMed ID: 12965950
[No Abstract] [Full Text] [Related]
20. The relative safety of ephedra compared with other herbal products.
Kimmel SE
Ann Intern Med; 2003 Aug; 139(3):234. PubMed ID: 12899599
[No Abstract] [Full Text] [Related]
[Next] [New Search]
